Early metabolic response in sequential FDG-PET/CT under...

  • Main
  • 2018 / 7
  • Early metabolic response in sequential FDG-PET/CT under...

Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial

Berger, Anne Katrin, Lücke, Stephan, Abel, Ulrich, Haag, Georg Martin, Grüllich, Carsten, Stange, Annika, Dietrich, Mareike, Apostolidis, Leonidas, Freitag, Angelika, Trierweiler, Claudia, von Gall, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-018-0152-4
Date:
July, 2018
File:
PDF, 612 KB
english, 2018
Conversion to is in progress
Conversion to is failed